Breakthrough? This American Pharma Company Is Testing A 5-Day COVID-19 Cure

We’ve been hearing a lot about vaccines, but this company is thinking of a cure

New Jersey-based pharmaceutical company, Merck, just announced the phase2a findings of their “COVID cure.” The drug, which is an antiviral Therapeutic Molnupiravir, shows promising results amongst patients in early stages of COVID-19. It reduces the presence of the virus and its side effects within an average of 5 days.

The antiviral, which is a collaboration with Ridgeback Biotherapeutics, is currently in phase 2/3 trials which are due to be completed around May.

Sounds promising…

Great News: Bahrain Has Officially Hit The 300k Vaccination Benchmark

Bahrain Is Gearing Up Vaccinations With 300K Additional Doses In March Alone

Update: You Can Now Choose A Second Preference Vaccine On The BeAware App